Evaluation of the in vitro Effect of the Interferon Produced by Bovine Ephemeral Fever Virus on Foot and Mouth Disease Virus

Ibrahim, Ehab El-sayed; A.A., Albehwar; Attia, Heba; Abdrabo, Mohamed A.; Kodeir, Mohamed Hassan

doi:10.21608/javs.2024.299401.1361

	Evaluation of the in vitro Effect of the Interferon Produced by Bovine Ephemeral Fever Virus on Foot and Mouth Disease Virus
Journal of Applied Veterinary Sciences
Article 3, Volume 9, Issue 4, October 2024, Page 17-25 PDF (336.27 K)
Document Type: Original Article
DOI: 10.21608/javs.2024.299401.1361
View on SCiNiTO
Authors
Ehab El-sayed Ibrahim ¹; Albehwar A.A.²; Heba Attia¹; Mohamed A. Abdrabo³; Mohamed Hassan Kodeir²
¹Department of Foot and Mouth disease Vaccine Research; Veterinary Serum and Vaccine Research Institute (VSVRI), Abasia, Cairo; Agricultural Research Center (ARC), Egypt
²Department of Pet Animal Vaccine Research; Veterinary Serum and Vaccine Research Institute (VSVRI), Abasia, Cairo; Agricultural Research Center (ARC), Egypt
³Central Laboratory for Evaluation of Veterinary Biologics, Abasia, Cairo; Agricultural Research Center (ARC), Egypt
Abstract
This paper presents a potential strategy for the development of an antiviral agent against FMDV, specifically O Pan-Asia-2, A Iran 05 and SAT2/EGY/2012. Examining the potential use of interferon from the Bovine Ephemeral Fever Virus (BEFV) as a therapy is an intriguing approach. In order to test the cell toxicity and anti-FMDV in African green monkey kidney cell (Vero) and Baby Hamster Kidney Cell (BHK) cell lines up to serial dilutions of 10^-7, BEFV was used to produce interferon in Vero and MDBK cell lines 12, 24, and 48 hours after cell infection. The in vitro findings showed that the cell safety and the ability of the prepared interferon to exhibit antiviral effects against various three FMDV serotypes, especially when administered shortly before or concurrently with the virus, are encouraging. The highest anti-FMDV effective dilution of the obtained interferon, either by Vero or MDBK cells, ranged from 10^-3to 10^-4. This suggests that the interferon may be able to activate cellular antiviral mechanisms and disrupt FMDV infection. The next critical step will be conducting further in vivo studies to evaluate the efficacy, safety, and potential side effects of the interferon-based treatment. This will provide important insights into virus-host interactions and the broader therapeutic potential of this approach. Some key areas for future research could include: expanding the testing of the interferon against additional FMDV serotypes to assess its breadth of coverage; Optimizing the administration parameters, such as timing, dose, and route, to maximize the antiviral effect, Investigating the specific mechanisms by which the interferon inhibits FMDV replication and spread, Evaluating the interferon's impact on disease progression and transmission in animal models, Assessing any potential negative effects or toxicity in the treated animals. The development of effective antivirals against FMDV is critical for controlling outbreaks and protecting livestock. This research represents a promising line of investigation that warrants further study.
Keywords
Bovine Ephemeral Fever; Interferon; Foot and Mouth Disease; MDBK cells


References
Ahl R., and Rump, A., 1976. Assay of bovine interferons in cultures of the porcine cell line IBRS-2. Infect. Immun.14:603-606. https://doi.org/10.1128/iai.14.3.603-606.1976 Albehwar, A.M. Wafaa, M. Ismaeil Hiam, M. Fakhry and Hemmat, S. El-Emam., 2018.Molecular characterization of recent isolates of BEF virus in Egypt. Global J. Med. Res. Vet. Sci. Vet. Med. Vol. 18 Issue 2: 6-14, DOI:10.21608/bjas.2017.164028 Arzt, J., Juleff, N., Zhang, Z., and Rodriguez, L. L., 2011. "The Pathogenesis of Foot-and-Mouth Disease I: Viral Pathways in Cattle". Transboundary and Emerging Diseases. 58 (4):291–304. doi:10.1111/j.1865-1682.2011.01204.x. PMID 21366894. Charles E. Samuel, 1991. Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities; Virology, Volume 183, Issue 1, Pages 1-11. https://doi.org/10.1016/0042-6822(91)90112-o Cheon, H., Borden, E.C., and Stark, G.R., 2014. Interferons and their stimulated genes in the tumor microenvironment. In Seminars in oncology (Vol. 41, No. 2, pp. 156-173. WB Saunders. https://doi.org/10.1053/j.seminoncol.2014.02.002 Chinsangaram, J., Piccone, M. E., and Grubman, M. J., 1999. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol.73:9891-9898. https://doi.org/10.1128/JVI.73.12.9891-9898.1999 Chinsangaram, J., Koster, M., and Grubman, M. J., 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol.75:5498-5503. https://doi.org/10.1128/JVI.75.12.5498-5503.2001 De Andrea, M., Ravera, R., Gioia, D., Gariglio, M., and Landolfo, S., 2002. "The interferon system: an overview". European Journal of Paediatric Neurology. 6 Suppl A (6): A41–6, discussion A55–8. doi:10.1053/ejpn.2002.0573. PMID 12365360. S2CID 4523675 de Los Santos, T., de Avila Botton, S., Weiblen, R., and Grubman, M. J., 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol.80:1906-1914. https://doi.org/10.1128/JVI.80.4.1906-1914.2006 Desai, C. 2016. Meyler's side effects of drugs: The international encyclopedia of adverse drug reactions and interactions. Indian Journal of Pharmacology, 48(2), p.224. Diaz-San, S.F., Medina, G. N., Azzinaro, P., Gutkoska, J., Mogulothu, A., Attreed, S. E., Lombardi, K. R., Shields, J., Hudock, T. A., and de Los Santos, T., 2021. Use of Protein Pegylation to Prolong the Antiviral Effect of IFN Against FMDV. Frontiers in Microbiology, 12, 668890. https://doi.org/10.3389/fmicb.2021.668890 Dubovi, E.J., Fenner, F., and Maclachlan, N.J., 2011. Fenner’s Veterinary Virology. [electronic resource] edited by N. Maclachlan and Edward J. Dubovi. 4th ed. Elsevier/AP, p.362. Eweis, A. R. F., Hassan, K. M., Shoman, S. A. H., Taha, H. A., and Mohamed, E. E., 2022. Investigation of honey bee venom effect on the immunogenicity of foot-and-mouth disease vaccine in sheep. Open veterinary journal, 12(6), 919–928. https://doi.org/10.5455/OVJ.2022.v12.i6.18 Gamil, A. MOHAMED and Soliman M. EMAN, 2021. Effect of Vegetable Oils as Adjuvants on Immune Response to Polyvalent Foot and Mouth Disease Inactivated Vaccine. Journal of Applied Veterinary Sciences, 6(2): 37-43. DOI: 10.21608/javs.2021.154580 Grubman, M. J., and Baxt, B., 2004. Foot-and-mouth disease. Clin. Microbiol. Rev.17:465-493. He, C. Q., Liu, Y. X., Wang, H. M., Hou, P. L., He, H. B., and Ding, N. Z., 2016. New genetic mechanism, origin and population dynamic of bovine ephemeral fever virus; Veterinary Microbiology, Elsevier https://doi.org/10.1016/j.vetmic.2015.10.029 Jorg,H. Fritz, 2016.Effects of Interferons and Viruses on Metabolism; Front. Immunol., 21. https://doi.org/10.3389/fimmu.2016.00630 Katze, M. G., He, Y., and Gale, M., J.r., 2002. Viruses and interferon: a fight for supremacy; Nature Reviews Immunology volume 2, pages675–687. https://doi.org/10.1038/nri888 Lee, G., Kang, H. R., Kim, A., Park, J. H., Lee, M. J., and Kim, S. M., 2023. Preventive effects of quercetin against foot-and-mouth disease virus in vitro and in vivo by inducing type I interferon. Frontiers in Microbiology, 14, 1121830. https://doi.org/10.3389/fmicb.2023.1121830 Lin, F.C. and Young, H.A., 2014. Interferons: success in anti-viral immunotherapy. Cytokine and Growth Factor Reviews, 25(4), pp.369-376. https://doi.org/10.1016/j.cytogfr.2014.07.015 Medina, G. N., de Los Santos, T., and Diaz-San Segundo F., 2020. Use of IFN-Based Biotherapeutics to Harness the Host Against Foot-And-Mouth Disease. Frontiers in Veterinary Science, 7, 465. https://doi.org/10.3389/fvets.2020.00465 Moraes, M. P., de Los Santos, T., Koster, M., Turecek, T., Wang, H., Andreyev, V. G., and Grubman, M. J., 2007. Enhanced Antiviral Activity against Foot-and-Mouth Disease Virus by a Combination of Type I and II Porcine Interferons; ASM Journals Journal of Virology; Vol. 81, No. 13; DOI: https://doi.org/10.1128/jvi.02775-06 Nandi, S., and Negi, B. S., 1999.Bovine ephemeral fever: A review; Comp. Immun. Microbiol. Infect. Dis. 22: 81-91. https://doi.org/10.1016/s0147-9571(98)00027-7 Parkin, J., and Cohen B., 2001. "An overview of the immune system". Lancet. 357 (9270): 1777–89. doi:10.1016/S0140-6736(00)04904-7. PMID 11403834. S2CID 165986. Pestka, S., Langer, J. A., Zoon, K. C., and Samuel, C. E., 1987. Interferons and their actions. Annu. Rev Biochem. ; 56:317–332. https://doi.org/10.1146/annurev.bi.56.070187.003455 Saber, S.M., Albehwar A.M.A., Abas A.M., Alshamandy O.A.A., El-Said N.A. and Hamad M.Y., 2022. In vitro antiviral effect of interferon produced by bovine ephemeral fever virus against rift valley fever virus. Journal of Virological Sciences, 10(1): 1-7. Sarker, S. N., and Sen, G. C., 1998. Production, purification, and characterization of recombinant 2′,5′-oligoadenylate synthetases. Methods. 15:233–242. https://doi.org/10.1006/meth.1998.0627 Shabana, S. W. and ABD EL-Sadek, A. , 2021. Effect of Carbomer as an Adjuvant for Enhancement of Immune-Response Against FMD Vaccine. Journal of Applied Veterinary Sciences, 6(2): 27-36. DOI: 10.21608/javs.2021.154578 St George, T.D. 1993. The natural history of ephemeral fever of cattle. [Symposium paper]. ACIAR Proceedings-Australian Centre for International Agricultural Research (Australia). Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., and Schreiber, R. D., 1998. How cells respond to interferons. Annu Rev Biochem. 67:227–264. https://doi.org/10.1146/annurev.biochem.67.1.227 Stephanie Watson, 2020. Your Guide to Interferons; WebMD; Drugs and medications Stewart, II. W.E. 2012. The interferon system. Springer Science & Business Media.17 The Royal Society, 2002. Infectious disease in livestock, London, United Kingdom. https://royalsociety.org/news-resources/publications/2002/infectious-disease-livestock/ Tsunetsugu-Yokota, Y. 2008. Large-scale preparation of UV-inactivated SARS coronavirus virions for vaccine antigen. In SARS-and Other Coronaviruses Humana Press, Totowa, NJ. :119-126. https://doi.org/10.1007/978-1-59745-181-9_11 Tzipori, S. 1975. ‘The isolation of bovine ephemeral fever virus in cell cultures and evidence for auto interference’, The Australian Journal of Experimental Biology and Medical Science, 53(4), pp. 273–279. https://doi.org/10.1038/icb.1975.30 Zhang, Z. D., Hutching, G., Kitching, P., and Alexandersen, S., 2002. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells. Arch. Virol.147:2157-2167. https://doi.org/10.1007/s00705-002-0867-6
Statistics Article View: 590 PDF Download: 497